✦ LIBER ✦
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer
✍ Scribed by Olivier Rixe; Sandra X. Franco; Denise A. Yardley; Stephen R. Johnston; Miguel Martin; Banu K. Arun; Stephen P. Letrent; Hope S. Rugo
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 367 KB
- Volume
- 64
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.